½ðÄê»á¡¤(jinnianhui)½ð×ÖÕÐÅÆ³ÏÐÅÖÁÉÏ-Gold Annual Meeting

  • »¶Ó­À´µ½ÉϺ£Í¨Îµ£¡

    021-54845833/15800441009

    Æ·Öʱ£Ö¤ ¡¤ ͨεÊÔ¼Á

    µ±Ç°Î»ÖÃ: Ê×Ò³ > ¿ÆÑвúÆ· > ¿ÆÑп¹Ìå > Ò»¿¹ > Íÿ¹LDLRAD3¶à¿Ë¡¿¹Ìå

    ²úÆ·ÖÐÐÄ

    ×îвúÆ·

    • Íÿ¹LDLRAD3¶à¿Ë¡¿¹Ìå

      ¹æ¸ñ£º
      ¼Û¸ñ£º£¤
      • Æ·ÅÆ : ͨεÉúÎï
      • Ŀ¼ºÅ : TW11233
      • Ó¦Óà : ½ö¹©¿ÆÑÐʹÓÃ
      • »õÆÚ : ÏÖ»õ
      • ¹æ¸ñ £º100ul/200ul/25ul
    • ÉÌÆ·ÏêÇé
    • ²Î¿¼ÎÄÏ×
    • ˵Ã÷ÊéÏÂÔØ
    • ÉÌÆ·ÆÀÂÛ0
    • Ïà¹Ø²úÆ·

    ÖÐÎÄÃû³Æ£º Íÿ¹LDLRAD3¶à¿Ë¡¿¹Ìå

    Ó¢ÎÄÃû³Æ£º Anti-LDLRAD3 rabbit polyclonal antibody

    ±ð     Ãû£º LRAD3

    ¿¹     Ô­£º LDLRAD3

    ´¢     ´æ£º Àä¶³£¨-20¡æ£© ±Ü¹â

    ËÞ     Ö÷£º Rabbit

    ·´Ó¦ÖÖÊô£º Human Mouse

    Ïà¹ØÀà±ð£º Ò»¿¹

    ±ê ¼Ç Î Unconjugate

    ¿Ë¡ÀàÐÍ£º Unconjugate

    ¼¼Êõ¹æ¸ñ

    Background:

    May influence APP processing, resulting in a decrease in sAPP-alpha production and increased amyloidogenic P3 peptide production By similarity.

    Applications:

    IF

    Name of antibody:

    LDLRAD3

    Immunogen:

    Synthesized peptide derived from internal of human LDLRAD3.

    Full name:

    low density lipoprotein receptor class A domain containing 3

    Synonyms£º

    LRAD3

    SwissProt:

    Q86YD5

    IF positive control:

    A549 cells

    IF Recommend dilution:

    100-500





    ¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿
    ¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿